(4AR, 10AR) -1-N-propyl-1,2,3,4,5,10,10A-octahydrobenzo G quinoline-6,7-diol and related compounds may be administered to the oral mucosa, nasal mucosa or Method for administration through the skin and pharmaceutical composition thereof

摘要

Disclosed are pharmaceutical compositions and methods for the administration of (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol or a pharmaceutically acceptable salt thereof and related compounds for the treatment of neurological disorder such as Parkinson's disease and restless leg syndrome.